Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

110 participants

Study Classification

OBSERVATIONAL

Study Start Date

2010-08-31

Study Completion Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of this study is to compare 2 different measurements of visceral fat that can be easily used in clinical practice (waist circumference versus bioelectric impedance) in relation to known risk factors of coronary artery disease in a large cohort of patients with type 2 diabetes and with a BMI range between 20-45 kg/m2

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus

NCT03132129

Diabetes Mellitus, Type 2 Diabetic Cardiomyopathies

RECRUITING

Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications

NCT06112197

Visceral Fat Insulin Resistance

UNKNOWN

Epicardial Adipose Tissue and Arterial Stiffness in People Living With Diabetes (METAB-CV-PWV)

NCT05681533

Diabetic Patients

UNKNOWN

Cardiovascular Disease CVD Constitutes a Significant Health Challenge for Individuals With Type 2 Diabetes Mellitus T2DM, Affecting Approximately 32% of This Population and Contributing Significantly to Global Mortality.Visceral Adipose Tissue VAT Accumulation Has Been Recognize

NCT07204782

Diabete Mellitus

NOT_YET_RECRUITING

Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control

NCT00021944

Atherosclerosis Cardiovascular Diseases Diabetes Mellitus +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Type 2 Diabetes Metabolic Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Established type 2 diabetes
* Age 18 - 80
* Body mass index (BMI) between 20-45 Kg/m2.
* Willing to undergo laboratory and anthropometric assessments.

Exclusion Criteria

* The study will not include women who are pregnant, or are not using reliable birth control methods or who they think that they might be pregnant due to potential risk of fetal affection.
* Subjects with known malignancy, treated or untreated will be excluded (except treated skin melanoma).
* Subjects with major psychological problems or a major eating disorder will be excluded.
* Subjects with heart Pacemaker or any other electronic devices attached to their body will be excluded.
* Subjects with confirmed type 1 diabetes or positive anti GAD antibodies test will be excluded

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No